Vis enkel innførsel

dc.contributor.authorShah, Ajay Kumar
dc.date.accessioned2019-09-20T11:09:48Z
dc.date.available2019-09-20T11:09:48Z
dc.date.issued2019
dc.identifier.urihttp://hdl.handle.net/11250/2618017
dc.description.abstractThis thesis studies the potential for using molecular testing for ESBL in Norwegian hospitals. Background material was obtained by checking the prices of existing kits, doing an interview with one of Norway’s foremost experts on ESBL testing and performing calculations based on public statistics. A survey was then performed that was expected to form the basis of a price sensitivity analysis. The number of respondents was too low for statistical analysis, but a very rough estimate for the kit prices that microbiological hospital labs are willing to pay was obtained. The realism of this price level is discussed. All responses were from medium sized hospitals. They also stated that the throughput they needed would be 8 to 24 samples per run. This confirms theoretical estimates of the throughput needed for Norwegian hospitals of medium size.nb_NO
dc.language.isoengnb_NO
dc.subjectESBL detectionnb_NO
dc.subjectprice sensitivitynb_NO
dc.subjectprices of kits and instrumentsnb_NO
dc.titlePrice sensitivity in the clinical testing market for Extended-Spectrum Beta-Lactamasenb_NO
dc.typeMaster thesisnb_NO
dc.subject.nsiVDP::Teknologi: 500::Bioteknologi: 590nb_NO


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel